Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yanhuang Xiaoxintong Capsule is a Traditional Chinese Medicine (TCM) formulation developed by the Hunan University of Traditional Chinese Medicine, specifically intended for the treatment of cardiovascular conditions such as coronary heart disease and angina pectoris. The preparation is designed to promote blood circulation, resolve blood stasis, and alleviate chest pain (活血化瘀, 理气止痛). It typically comprises a combination of herbal extracts, including *Salvia miltiorrhiza* (Danshen), *Panax notoginseng* (Sanqi), and *Dalbergia odorifera* (Jiangxiang). Pharmacological studies indicate that the capsule helps improve myocardial ischemia, reduces blood viscosity, and modulates lipid metabolism, thereby providing therapeutic benefits for patients with chronic stable angina and related ischemic heart diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yanhuang Xiaoxintong Capsule.